Review ArticleClinical Review

Night Sweats: A Systematic Review of the Literature

James W. Mold, Barbara J. Holtzclaw and Laine McCarthy
The Journal of the American Board of Family Medicine November 2012, 25 (6) 878-893; DOI: https://doi.org/10.3122/jabfm.2012.06.120033

References

  1. 1.↵
    1. Kroenke K
    . The interface between physical and psychological symptoms. Prim Care Companion J Clin Psychiatry 2003;5(suppl 7):11–8.
    OpenUrl
  2. 2.↵
    1. Ely JW,
    2. Osheroff JA,
    3. Ferguson KJ,
    4. Chambliss ML,
    5. Vinson DC,
    6. Moore JL
    . Lifelong self-directed learning using a computer database of clinical questions. J Fam Pract 1997;45:382–8.
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Smetana GW,
    2. Aronson MD,
    3. Sokol HN
    . Approach to the patient with night sweats. Version 19.2. UpToDate. 2011. Available at: www.uptodate.com/contents/approach-to-the-patient-with-night-sweats?source=search_result&search=approach+to+the+patient+with+night+sweats&selectedTitle=1%7E150. Accessed October 14, 2011.
  4. 4.↵
    1. Sato K,
    2. Kang WH,
    3. Saga K,
    4. Sato KT
    . Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 1989;20:537–63.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Sato K,
    2. Sato F
    . Individual variations in structure and function of human eccrine sweat gland. Am J Physiol 1983;245:R203–8.
    OpenUrlPubMed
  6. 6.↵
    1. Shibasaki M,
    2. Crandall CG
    . Mechanisms and controllers of eccrine sweating in humans. Front Biosci 2010;2:685–96.
    OpenUrl
  7. 7.↵
    1. Gobbi PG,
    2. Pieresca C,
    3. Ricciardi L,
    4. Vacchi S,
    5. Bertoloni D,
    6. Rossi A,
    7. Grignani G,
    8. Rutigliano L,
    9. Ascari E
    . Night sweats in Hodgkin's disease. A manifestation of preceding minor febrile pulses. Cancer 1990;65:2074–7.
    OpenUrlPubMed
  8. 8.↵
    1. Crandall CJ,
    2. Crawford SL,
    3. Gold EB
    . Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 2006;119(suppl 1):S52–60.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Deecher DC,
    2. Dorries K
    . Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Mental Health 2007;10:247–57.
    OpenUrl
  10. 10.↵
    IUPS Thermal Commission. Glossary of terms for thermal physiology. 3rd ed. Jpn J Physiol 2001;51:i–xxxvi.
    OpenUrl
  11. 11.↵
    1. Tayefeh F,
    2. Plattner O,
    3. Sessler DI,
    4. Ikeda T,
    5. Marder D
    . Circadian changes in the sweating-to-vasoconstriction interthreshold range. Pflugers Archiv Eur J Physiol 1998;435:402–6.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Holtzclaw BJ
    . Circadian rhythmicity and homeostatic stability in thermoregulation. Biol Res Nurs 2001;2:221–35.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Timbal J,
    2. Colin J,
    3. Boutelier C
    . Circadian variations in the sweating mechanism. J Appl Physiol 1975;39:226–30.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Morris C,
    2. Atkinson G,
    3. Drust B,
    4. Marrin K,
    5. Gregson W
    . Human core temperature responses during exercise and subsequent recovery: an important interaction between diurnal variation and measurement site. Chronobiol Int 2009;26:560–75.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Aoki K,
    2. Kondo N,
    3. Shibasaki M,
    4. Takano S,
    5. Tominaga H,
    6. Katsuura T
    . Circadian variation of sweating responses to passive heat stress. Acta Physiol Scand 1997;161:397–402.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Kenny GP,
    2. Periard J,
    3. Journeay WS,
    4. Sigal RJ,
    5. Reardon FD
    . Effect of exercise intensity on the postexercise sweating threshold. J Appl Physiol 2003;95:2355–60.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Kreider RB,
    2. Fry AC,
    3. O'Toole ML
    . Overtraining in sport. Champaign, IL: Human Kinetics; 1998. p. 5.
  18. 18.↵
    1. Armstrong LE,
    2. Stoppani J
    . Central nervous system control of heat acclimation adaptations: an emerging paradigm. Rev Neurosci 2002;13:271–85.
    OpenUrlPubMedWeb of Science
  19. 19.↵
    1. Abram WP,
    2. Allen JA,
    3. Roddie IC
    . The effect of pain on human sweating. J Physiol 1973;235:741–7.
    OpenUrlPubMed
  20. 20.↵
    1. Maple S,
    2. Bradshaw CM,
    3. Szabadi E
    . Pharmacological responsiveness of sweat glands in anxious patients and healthy volunteers. Br J Psychiatry 1982;141:154–61.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. van den Broek MD,
    2. Bradshaw CM,
    3. Szabadi E
    . The effects of a psychological ‘stressor' and raised ambient temperature on the pharmacological responsiveness of human eccrine sweat glands: implications for sweat gland hyper-responsiveness in anxiety states. Eur J Clin Pharmacol 1984;26:209–213.
    OpenUrlPubMed
  22. 22.↵
    1. Cabanac M
    . Adjustable set point: to honor Harold T. Hammel. J Appl Physiol 2006;100:1338–46.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Murphy PJ,
    2. Campbell SS
    . Nighttime drop in body temperature: a physiological trigger for sleep onset? Sleep 1997;20:505–11.
    OpenUrlPubMed
  24. 24.↵
    1. Avery D,
    2. Wildschiodtz G,
    3. Rafaelsen O
    . REM latency and temperature in affective disorder before and after treatment. Biol Psychiatry 1982;17:463–70.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    1. Halaris A
    1. Avery DH
    . REM sleep and temperature regulation in affective disorder. In: Halaris A, editor. Chronobiology and neuropsychiatric disorders. New York, NY: Elsevier; 1987. p. 75–101.
  26. 26.↵
    1. Avery DH,
    2. Wildschiodtz G,
    3. Rafaelsen OJ
    . Nocturnal temperature in affective disorder. J Affect Disord 1982;4:61–71.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Avery DH,
    2. Wildschiodtz G,
    3. Smallwood RG,
    4. Martin D,
    5. Rafaelsen OJ
    . REM latency and core temperature relationships in primary depression. Acta Psychiatr Scand 1986;74:269–80.
    OpenUrlPubMedWeb of Science
  28. 28.↵
    1. Schwartz PJ,
    2. Rosenthal NE,
    3. Kajimura N,
    4. Han L,
    5. Turner EH,
    6. Bender C,
    7. Wehr TA
    . Ultradian oscillations in cranial thermoregulation and electroencephalographic slow-wave activity during sleep are abnormal in humans with annual winter depression. Brain Res 2000;866:152–67.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Szuba MP,
    2. Guze BH,
    3. Baxter LR Jr.
    . Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects. Biol Psychiatry 1997;42:1130–7.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. von Zerssen D,
    2. Barthelmes H,
    3. Dirlich G,
    4. Doerr P,
    5. Emrich HM,
    6. von Lindern L,
    7. Lund R,
    8. Pirke KM
    . Circadian rhythms in endogenous depression. Psychiatry Res 1985;16:51–63.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Avery DH,
    2. Shah SH,
    3. Eder DN,
    4. Wildschiodtz G
    . Nocturnal sweating and temperature in depression. Acta Psychiatr Scand 1999;100:295–301.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Levin P,
    2. Koella WP
    1. Gnirss F,
    2. Schneider D
    . Patterns of spontaneous autonomic activities during human NREM sleep. In: Levin P, Koella WP, editors. Sleep. Basel, Switzerland: Karger; 1975. p. 352–5.
  33. 33.↵
    1. Low PA
    1. Ogawa T,
    2. Low PA
    . Autonomic regulation of temperature and sweating. In: Low PA, editor. Clinical autonomic disorders. Philadelphia, PA: Lippincott-Raven Publishers; 1997, p. 83–96.
  34. 34.↵
    1. Noll G,
    2. Elam M,
    3. Kunimoto M,
    4. Karlsson T,
    5. Wallin BG
    . Skin sympathetic nerve activity and effector function during sleep in humans. Acta Physiol Scand 1994;151:319–29.
    OpenUrlPubMedWeb of Science
  35. 35.↵
    1. Spreng LF,
    2. Johnson LC,
    3. Lubin A
    . Autonomic correlates of eye movement bursts during stage REM sleep. Psychophysiology 1968;4:311–23.
    OpenUrlPubMed
  36. 36.↵
    1. Wehr TA
    . A brain-warming function for REM sleep. Neurosci Biobehav Rev 1992;16:379–97.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Mold JW,
    2. Mathew MK,
    3. Belgore S,
    4. DeHaven M
    . Prevalence of night sweats in primary care patients: an OKPRN and TAFP-Net collaborative study. J Fam Pract 2002;51:452–6.
    OpenUrlPubMed
  38. 38.↵
    1. Mold JW,
    2. Goodrich S,
    3. Orr W
    . Associations between subjective night sweats and sleep study findings. JABFM 2008;21:96–100.
    OpenUrlPubMed
  39. 39.↵
    1. Mold JW,
    2. Woolley JH,
    3. Nagykaldi Z
    . Associations between night sweats and other sleep disturbances: an OKPRN study. Ann Fam Med 2006;4:423–6.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Mold JW,
    2. Roberts M,
    3. Aboshady HM
    . Prevalence and predictors of night sweats, day sweats, and hot flashes in older primary care patients: an OKPRN study. Ann Fam Med 2004;2:391–7.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Cheong YS,
    2. Mold JW,
    3. Park EW
    . The epidemiology of night sweats in a South Korean primary care population: a Chunan Network study. 2002. Unpublished.
  42. 42.↵
    1. Viera AJ,
    2. Bond MM,
    3. Yates SW
    . Diagnosing night sweats. Am Family Phys 2003;67:1019–24.
    OpenUrlPubMedWeb of Science
  43. 43.↵
    1. Su CW,
    2. Gaskie S,
    3. Hitchcock K,
    4. Johnson L,
    5. Su CW,
    6. Gaskie S,
    7. Hitchcock K,
    8. Johnson L
    . Clinical inquiries. What's the best diagnostic evaluation of night sweats? J Family Pract 2007;56:493–5.
    OpenUrlPubMed
  44. 44.↵
    1. Chambliss ML
    . Frequently asked questions from clinical practice. What is the appropriate diagnostic approach for patients who complain of night sweats? Arch Fam Med 1999;8:168–9.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Walker HK,
    2. Hall WD,
    3. Hurst JW
    1. Dall L,
    2. Stanford JF
    . Fever, chills, and night sweats. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston, MA, London, UK: Butterworths; 1990. p. 944–8.
  46. 46.↵
    1. Mold JW,
    2. Lawler F
    . The prognostic implications of night sweats in two cohorts of older patients. J Am Board Fam Med 2010;23:97–103.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Lister TA,
    2. Crowther D,
    3. Sutcliffe SB,
    4. Glatstein E,
    5. Canellos GP,
    6. Young RC,
    7. Rosenberg SA,
    8. Coltman CA,
    9. Tubiana M
    . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630–6.
    OpenUrlAbstract
  48. 48.↵
    1. Gobbi PG,
    2. Cavalli C,
    3. Gendarini A,
    4. Crema A,
    5. Ricevuti G,
    6. Federico M,
    7. Di Prisco U,
    8. Ascari E
    . Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer 1985;56:2874–80.
    OpenUrlPubMed
  49. 49.↵
    1. Crnkovich MJ
    . Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. J Clin Oncol 1987;5:1041.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Rabeneck L,
    2. Crane MM,
    3. Risser JM,
    4. Lacke CE,
    5. Wray NP
    . A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J Gen Intern Med 1993;8:5–9.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Redd JT,
    2. Susser E
    . Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation. Am J Public Health 1997;87:1543–7.
    OpenUrlPubMedWeb of Science
  52. 52.↵
    1. El-Solh A,
    2. Mylotte J,
    3. Sherif S,
    4. Serghani J,
    5. Grant BJ
    . Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med 1997;155:1711–6.
    OpenUrlPubMedWeb of Science
  53. 53.
    1. Smetana GW
    . Diagnosis of night sweats. JAMA 1993;270:2502–3.
    OpenUrlCrossRef
  54. 54.
    1. Casey K,
    2. Cohen F,
    3. Halloran J,
    4. Hughes A
    1. Holtzclaw BJ
    . Fever and night sweats. In: Casey K, Cohen F, Halloran J, Hughes A, editors. ANAC core curriculum for HIV/AIDS nursing. Malibu, CA: NurseCom; 1996. p. 211–7.
  55. 55.
    1. Lea MJ,
    2. Aber RC
    . Descriptive epidemiology of night sweats upon admission to a university hospital. South Med J 1985;78:1065–67.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.
    1. Quigley CS,
    2. Baines M
    . Descriptive epidemiology of sweating in a hospice population. J Palliat Care 1997;13:22–6.
    OpenUrlPubMedWeb of Science
  57. 57.
    1. Reynolds WA
    . Are night sweats a sign of esophageal reflux? J Clin Gastroenterol 1989;11:590–1.
    OpenUrlPubMed
  58. 58.
    1. Suwanprathes P,
    2. Won C,
    3. Komoltri C,
    4. Nana A,
    5. Kotchabhakdi N,
    6. Guilleminault C
    . Epidemiology of sleep-related complaints associated with sleep-disordered breathing in Bangkok, Thailand. Sleep Med 2010;11:1025–30.
    OpenUrlPubMed
  59. 59.
    1. Hudnall SD,
    2. Chen T,
    3. Brown K,
    4. Angel T,
    5. Schwartz MR,
    6. Tyring SK
    . Human herpesvirus-8-positive microvenular hemangioma in POEMS syndrome. Arch Pathol Lab Med 2003;127:1034–6.
    OpenUrlPubMed
  60. 60.
    1. Crouch R,
    2. Akhras V,
    3. Sarkany R
    . Schnitzler's syndrome: successful treatment with anakinra. Aust J Dermatol 2007;48:178–81.
    OpenUrl
  61. 61.
    1. Morris GC,
    2. Thomas TP
    . Night sweats—presentation of an often forgotten diagnosis. Br J Clin Pract 1991;45:145.
    OpenUrlPubMed
  62. 62.
    1. Schattner A,
    2. Klepfish A,
    3. Caspi A
    . Chronic aortic dissection presenting as a prolonged febrile disease and arterial embolization. Chest 1996;110:1111–4.
    OpenUrlCrossRefPubMedWeb of Science
  63. 63.
    1. Becker RC,
    2. Giuliani M,
    3. Alpert JS
    . Nocturnal diaphoresis and coronary artery spasm. Contribution of the parasympathetic nervous system. Cleve Clin J Med 1987;54:515–8.
    OpenUrlAbstract/FREE Full Text
  64. 64.
    1. Raff SB,
    2. Gershberg H
    . Night sweats. A dominant symptom in diabetes insipidus. JAMA 1975;234:1252–3.
    OpenUrlCrossRefPubMed
  65. 65.
    1. Jayapaul M,
    2. Williams MR,
    3. Davies DP,
    4. Large DM
    . Recurrent painful unilateral gynaecomastia—interactions between hyperthyroidism and hypogonadism. Andrologia 2006;38:31–3.
    OpenUrlPubMed
  66. 66.
    1. Bollinger RC,
    2. Brookmeyer RS,
    3. Mehendale SM,
    4. Paranjape RS,
    5. Shepherd ME,
    6. Gadkari DA,
    7. Quinn TC
    . Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997;278:2085–9.
    OpenUrlCrossRefPubMedWeb of Science
  67. 67.
    1. Veugelers PJ,
    2. Kaldor JM,
    3. Strathdee SA,
    4. Page-Shafer KA,
    5. Schechter MT,
    6. Coutinho RA,
    7. Keet IP,
    8. van Griensven GJ
    . Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1997;176:112–7.
    OpenUrlAbstract/FREE Full Text
  68. 68.
    1. Fox R,
    2. Eldred LJ,
    3. Fuchs EJ,
    4. Kaslow RA,
    5. Visscher BR,
    6. Ho M,
    7. Phair JP,
    8. Polk BF
    . Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men. AIDS 1987;1:35–8.
    OpenUrlPubMedWeb of Science
  69. 69.
    1. El-Sadr W,
    2. Goetz RR,
    3. Sorrell S,
    4. Joseph M,
    5. Ehrhardt A,
    6. Gorman JM
    . Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY. Arch Intern Med 1992;152:1653–9.
    OpenUrlCrossRefPubMedWeb of Science
  70. 70.
    1. Poluri A,
    2. Shah KG,
    3. Carew JF,
    4. Shaha AR,
    5. Har-El G,
    6. Lucente FE,
    7. Singh B
    . Hodgkin's disease of the head and neck in human immunodeficiency virus-infected patients. Am J Otolaryngol 2002;23:12–6.
    OpenUrlPubMed
  71. 71.
    1. Tirelli U,
    2. Vaccher E,
    3. Zagonel V,
    4. Saracchini S,
    5. Bertola G,
    6. Serraino D,
    7. Monfardini S,
    8. Carbone A
    . Persistent generalized lymphadenopathy syndrome vs ‘AIDS'-unrelated malignant lymphoma: comparison of presenting clinical and laboratory findings in 88 patients. AIDS and Related Syndromes Study Group. Tumori 1989;75:222–5.
    OpenUrlPubMed
  72. 72.
    1. Corbett EL,
    2. Zezai A,
    3. Cheung YB,
    4. Bandason T,
    5. Dauya E,
    6. Munyati SS,
    7. Butterworth AE,
    8. Rusikaniko S,
    9. Churchyard GJ,
    10. Mungofa S,
    11. Hayes RJ,
    12. Mason PR
    . Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ 2010;88:13–21.
    OpenUrlCrossRefPubMedWeb of Science
  73. 73.
    1. Day JH,
    2. Charalambous S,
    3. Fielding KL,
    4. Hayes RJ,
    5. Churchyard GJ,
    6. Grant AD
    . Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006;10:523–9.
    OpenUrlPubMedWeb of Science
  74. 74.
    1. Kemper CA,
    2. Meng TC,
    3. Nussbaum J,
    4. Chiu J,
    5. Feigal DF,
    6. Bartok AE,
    7. Leedom JM,
    8. Tilles JG,
    9. Deresinski SC,
    10. McCutchan JA
    . Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Ann Intern Med 1992;116:466–72.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.
    1. Hoy J,
    2. Mijch A,
    3. Sandland M,
    4. Grayson L,
    5. Lucas R,
    6. Dwyer B
    . Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis 1990;161:801–5.
    OpenUrlAbstract/FREE Full Text
  76. 76.
    1. Young LS,
    2. Wiviott L,
    3. Wu M,
    4. Kolonoski P,
    5. Bolan R,
    6. Inderlied CB
    . Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991;338:1107–9.
    OpenUrlCrossRefPubMedWeb of Science
  77. 77.
    1. Singer J,
    2. Thorne A,
    3. Khorasheh S,
    4. Raboud JM,
    5. Wu AW,
    6. Salit I,
    7. Tsoukas CM,
    8. Lemieux C,
    9. Shafran SD
    . Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. Int J STD AIDS 2000;11:212–9.
    OpenUrlAbstract/FREE Full Text
  78. 78.
    1. Cain KP,
    2. McCarthy KD,
    3. Heilig CM,
    4. Monkongdee P,
    5. Tasaneeyapan T,
    6. Kanara N,
    7. Kimerling ME,
    8. Chheng P,
    9. Thai S,
    10. Sar B,
    11. Phanuphak P,
    12. Teeratakulpisarn N,
    13. Phanuphak N,
    14. Nguyen HD,
    15. Hoang TQ,
    16. Le HT,
    17. Varma JK
    . An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010;362:707–16.
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.
    1. Lambore S,
    2. McSherry J,
    3. Kraus AS
    . Acute and chronic symptoms of mononucleosis. J Family Pract 1991;33:33–7.
    OpenUrlPubMedWeb of Science
  80. 80.
    1. Cohen R,
    2. Muzaffar S,
    3. Capellan J,
    4. Azar H,
    5. Chinikamwala M
    . The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996;109:420–3.
    OpenUrlCrossRefPubMedWeb of Science
  81. 81.
    1. El-Solh AA,
    2. Hsiao CB,
    3. Goodnough S,
    4. Serghani J,
    5. Grant BJ
    . Predicting active pulmonary tuberculosis using an artificial neural network. Chest 1999;116:968–73.
    OpenUrlCrossRefPubMedWeb of Science
  82. 82.
    1. Benger A,
    2. Rennie RP,
    3. Roberts JT,
    4. Thornley JH,
    5. Scholten T
    . A human coenurus infection in Canada. Am J Trop Med Hyg 1981;30:638–44.
    OpenUrlAbstract/FREE Full Text
  83. 83.
    1. Babbott SF,
    2. Pearson VE
    . Sertraline-related night sweats. Ann Intern Med 1999;130:242–3.
    OpenUrl
  84. 84.
    1. Pierre JM,
    2. Guze BH
    . Benztropine for venlafaxine-induced night sweats. J Clin Psychopharmacol 2000;20:269.
    OpenUrlCrossRefPubMed
  85. 85.
    1. Martin AF,
    2. Figueroa SC,
    3. Merino Mde L,
    4. Hurlee AD
    . Hyperhidrosis in association with efavirenz. AIDS Patient Care STDS 2009;23:143–5.
    OpenUrlPubMed
  86. 86.
    1. Deutsch GS,
    2. Yeh KA,
    3. Bates WB,
    4. Tannehill WB
    . Embolization for management of hepatic hemangiomas. Am Surg 2001;67:159–64.
    OpenUrlPubMed
  87. 87.
    1. Bollard CM,
    2. Aguilar L,
    3. Straathof KC,
    4. Gahn B,
    5. Huls MH,
    6. Rousseau A,
    7. Sixbey J,
    8. Gresik MV,
    9. Carrum G,
    10. Hudson M,
    11. Dilloo D,
    12. Gee A,
    13. Brenner MK,
    14. Rooney CM,
    15. Heslop HE
    . Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 2004;200:1623–33.
    OpenUrlAbstract/FREE Full Text
  88. 88.
    1. Abba AA,
    2. Bamgboye AE,
    3. Afzal M,
    4. Rahmatullah RA
    . Lymphadenopathy in adults. A clinicopathological analysis. Saudi Med J 2002;23:282–6.
    OpenUrlPubMed
  89. 89.
    1. Pardanani A,
    2. Gotlib JR,
    3. Jamieson C,
    4. Cortes JE,
    5. Talpaz M,
    6. Stone RM,
    7. Silverman MH,
    8. Gilliland DG,
    9. Shorr J,
    10. Tefferi A
    . Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. J Clin Oncol 2011;29:789–96.
    OpenUrlAbstract/FREE Full Text
  90. 90.
    1. Mauri D,
    2. Pentheroudakis G,
    3. Tolis C,
    4. Chojnacka M,
    5. Pavlidis N
    . Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation. Urol Oncol 2005;23:318–22.
    OpenUrlPubMed
  91. 91.
    1. Kalichman SC,
    2. Sikkema KJ,
    3. Somlai A
    . Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds. J Pers Assess 1995;64:86–100.
    OpenUrlCrossRefPubMedWeb of Science
  92. 92.
    1. Marshall JR
    . The treatment of night terrors associated with the posttraumatic syndrome. Am J Psychiatry 1975;132:293–5.
    OpenUrlPubMedWeb of Science
  93. 93.
    1. Margraf J,
    2. Taylor B,
    3. Ehlers A,
    4. Roth WT,
    5. Agras WS
    . Panic attacks in the natural environment. J Nerv Ment Dis 1987;175:558–65.
    OpenUrlPubMedWeb of Science
  94. 94.
    1. Smalley SR,
    2. Cupps RE,
    3. Anderson JA,
    4. Ilstrup DM,
    5. McDonald TJ,
    6. Weiland LH,
    7. Deremee RD
    . Polymorphic reticulosis limited to the upper aerodigestive tract—natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys 1988;15:599–605.
    OpenUrlPubMedWeb of Science
  95. 95.
    1. Gale EA,
    2. Tattersall RB
    . Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979;1:1049–52.
    OpenUrlPubMedWeb of Science
  96. 96.
    1. Wachholtz A,
    2. Binks M,
    3. Suzuki A,
    4. Eisenson H
    . Sleep disturbance and pain in an obese residential treatment-seeking population. Clin J Pain 2009;25:584–9.
    OpenUrlPubMed
  97. 97.
    1. Zahradnik JM,
    2. Spencer MJ,
    3. Porter DD
    . Adenovirus infection in the immunocompromised patient. Am J Med 1980;68:725–32.
    OpenUrlCrossRefPubMedWeb of Science
  98. 98.
    1. Malani AN,
    2. Aronoff DM,
    3. Bradley SF,
    4. Kauffman CA
    . Cardiobacterium hominis endocarditis: two cases and a review of the literature. Eur J Clin Microbiol Infect Dis 2006;25:587–95.
    OpenUrlCrossRefPubMed
  99. 99.
    1. Gaines H,
    2. von Sydow M,
    3. Pehrson PO,
    4. Lundbegh P
    . Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988;297:1363–8.
    OpenUrlAbstract/FREE Full Text
  100. 100.
    1. Deeks SG,
    2. Kitchen CMR,
    3. Liu L,
    4. Guo H,
    5. Gascon R,
    6. Narvaez AB,
    7. Hunt P,
    8. Martin JN,
    9. Kahn JO,
    10. Levy J,
    11. McGrath MS,
    12. Hecht FM
    . Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004;104:942–7.
    OpenUrlAbstract/FREE Full Text
  101. 101.
    1. Yoong KY,
    2. Cheong I
    . A study of Malaysian drug addicts with human immunodeficiency virus infection. Int J STD AIDS 1997;8:118–23.
    OpenUrlAbstract/FREE Full Text
  102. 102.
    1. Kremer H,
    2. Sonnenberg-Schwan U,
    3. Arendt G,
    4. Brockmeyer NH,
    5. Potthoff A,
    6. Ulmer A,
    7. Graefe K,
    8. Lorenzen T,
    9. Starke W,
    10. Walker UA
    . HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. Eur J Med Res 2009;14:139–46.
    OpenUrlPubMed
  103. 103.
    1. Ajuluchukwu DC,
    2. Brown LS Jr.,
    3. Crummey FC,
    4. Foster KF Sr.,
    5. Ismail YI,
    6. Siddiqui N
    . Demographic, medical history and sexual correlates of HIV seropositive methadone maintained women. J Addict Dis 1993;12:105–20.
    OpenUrlCrossRefPubMed
  104. 104.
    1. Johnson MO,
    2. Stallworth T,
    3. Neilands TB
    . The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav 2003;7:109–17.
    OpenUrlCrossRefPubMedWeb of Science
  105. 105.
    1. Cunningham WE,
    2. Shapiro MF,
    3. Hays RD,
    4. Dixon WJ,
    5. Visscher BR,
    6. George WL,
    7. Ettl MK,
    8. Beck CK
    . Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998;104:129–36.
    OpenUrlCrossRefPubMedWeb of Science
  106. 106.
    1. Singh VR,
    2. Smith DK,
    3. Lawerence J,
    4. Kelly PC,
    5. Thomas AR,
    6. Spitz B,
    7. Sarosi GA
    . Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 1996;23:563–8.
    OpenUrlAbstract/FREE Full Text
  107. 107.
    1. Selwyn PA,
    2. Pumerantz AS,
    3. Durante A,
    4. Alcabes PG,
    5. Gourevitch MN,
    6. Boiselle PM,
    7. Elmore JG
    . Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients. AIDS 1998;12:885–93.
    OpenUrlCrossRefPubMedWeb of Science
  108. 108.
    1. Benson CA
    . Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994;3(suppl):S218–22.
    OpenUrlCrossRef
  109. 109.
    1. Richter C,
    2. Perenboom R,
    3. Mtoni I,
    4. Kitinya J,
    5. Chande H,
    6. Swai AB,
    7. Kazema RR,
    8. Chuwa LM
    . Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994;106:1471–5.
    OpenUrlCrossRefPubMedWeb of Science
  110. 110.
    1. Liam C-K,
    2. Pang Y-K,
    3. Poosparajah S
    . Pulmonary tuberculosis presenting as community-acquired pneumonia. Respirology 2006;11:786–92.
    OpenUrlCrossRefPubMedWeb of Science
  111. 111.
    1. Korzeniewska-Kosela M,
    2. FitzGerald JM,
    3. Vedal S,
    4. Allen EA,
    5. Schechter MT,
    6. Lawson L,
    7. Phillips P,
    8. Black W,
    9. Montaner JS
    . Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. CMAJ 1992;146:1927–34.
    OpenUrlAbstract
  112. 112.
    1. Cavalcanti ZdR,
    2. de Albuquerque MdFPM,
    3. Campello AR,
    4. Ximenes R,
    5. Montarroyos U,
    6. Vercosa MK
    . Characteristics of elderly tuberculosis patients in Recife, Brazil: a contribution to the tuberculosis control program. J Bras Pneumol 2006;32:535–43.
    OpenUrlPubMed
  113. 113.
    1. Van den Brande P,
    2. Vijgen J,
    3. Demedts M
    . Clinical spectrum of pulmonary tuberculosis in older patients: comparison with younger patients. J Gerontol 1991;46:M204–9.
    OpenUrlAbstract
  114. 114.
    1. Rawat J,
    2. Sindhwani G,
    3. Juyal R
    . Clinico-radiological profile of new smear positive pulmonary tuberculosis cases among young adult and elderly people in a tertiary care hospital at Deheradun (Uttarakhand). Indian J Tuberc 2008;55:84–90.
    OpenUrlPubMed
  115. 115.
    1. Alvarez S,
    2. Shell C,
    3. Berk SL
    . Pulmonary tuberculosis in elderly men. Am J Med 1987;82:602–6.
    OpenUrlCrossRefPubMedWeb of Science
  116. 116.
    1. Miller LG,
    2. Asch SM,
    3. Yu EI,
    4. Knowles L,
    5. Gelberg L,
    6. Davidson P
    . A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000;30:293–9.
    OpenUrlAbstract/FREE Full Text
  117. 117.
    1. Drobniewski F,
    2. Balabanova Y,
    3. Nikolayevsky V,
    4. Ruddy M,
    5. Kuznetzov S,
    6. Zakharova S,
    7. Melentyev A,
    8. Fedorin I
    . Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005;293:2726–31.
    OpenUrlCrossRefPubMedWeb of Science
  118. 118.
    1. Sun YJ,
    2. Lim TK,
    3. Ong AK,
    4. Ho BC,
    5. Seah GT,
    6. Paton NI
    . Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect Dis 2006;6:105.
    OpenUrlCrossRefPubMed
  119. 119.
    1. Khan R,
    2. Abid S,
    3. Jafri W,
    4. Abbas Z,
    5. Hameed K,
    6. Ahmad Z
    . Diagnostic dilemma of abdominal tuberculosis in non-HIV patients: an ongoing challenge for physicians. World J Gastroenterol 2006;12:6371–5.
    OpenUrlPubMedWeb of Science
  120. 120.
    1. O'Brien SM,
    2. Cunningham CC,
    3. Golenkov AK,
    4. Turkina AG,
    5. Novick SC,
    6. Rai KR
    . Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia. J Clin Oncol 2005;23:7697–702.
    OpenUrlAbstract/FREE Full Text
  121. 121.
    1. Furman RR,
    2. Forero-Torres A,
    3. Shustov A,
    4. Drachman JG
    . A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2010;51:228–35.
    OpenUrlCrossRefPubMedWeb of Science
  122. 122.
    1. Moran CA,
    2. Suster S,
    3. Abbondanzo SL
    . Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol 1997;28:332–8.
    OpenUrlCrossRefPubMedWeb of Science
  123. 123.
    1. Adedeji MO
    . The acute leukaemias in adults in Benin City, Nigeria. East Afr Med J 1989;66:64–8.
    OpenUrlPubMed
  124. 124.
    1. Osborne BM,
    2. Butler JJ,
    3. Guarda LA
    . Primary lymphoma of the liver. Ten cases and a review of the literature. Cancer 1985;56:2902–10.
    OpenUrlCrossRefPubMedWeb of Science
  125. 125.
    1. Le DT,
    2. Deavers M,
    3. Hunt K,
    4. Malpica A,
    5. Verschraegen CF
    . Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest 2003;21:682–9.
    OpenUrlPubMed
  126. 126.
    1. Tsai J-S,
    2. Wu C-H,
    3. Chiu T-Y,
    4. Hu W-Y,
    5. Chen C-Y
    . Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med 2006;20:617–22.
    OpenUrlAbstract/FREE Full Text
  127. 127.
    1. Mesa RA,
    2. Niblack J,
    3. Wadleigh M,
    4. Verstovsek S,
    5. Camoriano J,
    6. Barnes S,
    7. Tan AD,
    8. Atherton PJ,
    9. Sloan JA,
    10. Tefferi A
    . The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients. Cancer 2006;109:68–76.
    OpenUrl
  128. 128.
    1. Steensma DP,
    2. Mesa RA,
    3. Li C-Y,
    4. Gray L,
    5. Tefferi A
    . Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study. Blood 2002;99:2252–4.
    OpenUrlAbstract/FREE Full Text
  129. 129.
    1. Varki A,
    2. Lottenberg R,
    3. Griffith R,
    4. Reinhard E
    . The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine 1983;62:353–71.
    OpenUrlPubMed
  130. 130.
    1. Qiu L,
    2. Luo Y,
    3. Peng Y-L
    . Value of ultrasound examination in differential diagnosis of pancreatic lymphoma and pancreatic cancer. World J Gastroenterol 2008;14:6738–42.
    OpenUrlCrossRefPubMed
  131. 131.
    1. Capewell S,
    2. Chapman BJ,
    3. Alexander F,
    4. Greening AP,
    5. Crompton GK
    . Pulmonary eosinophilia with systemic features: therapy and prognosis. Respir Med 1992;86:485–90.
    OpenUrlPubMed
  132. 132.
    1. Wahner-Roedler DL,
    2. Olson EJ,
    3. Narayanan S,
    4. Sood R,
    5. Hanson AC,
    6. Loehrer LL,
    7. Sood A
    . Gender-specific differences in a patient population with obstructive sleep apnea–hypopnea syndrome. Gender Med 2007;4:329–38.
    OpenUrl
  133. 133.
    1. Freundlich B,
    2. Altman C,
    3. Snadorfi N,
    4. Greenberg M,
    5. Tomaszewski J
    . A profile of symptomatic patients with silicone breast implants: a Sjogrens-like syndrome. Semin Arthritis Rheum 1994;24(suppl 1):44–53.
    OpenUrlCrossRefPubMedWeb of Science
  134. 134.
    1. Maida V
    . Nabilone for the treatment of paraneoplastic night sweats: a report of four cases. J Palliat Med 2008;11:929–34.
    OpenUrlPubMed
  135. 135.
    1. Deaner PB
    . The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report. Palliat Med 2000;14:429–31.
    OpenUrlFREE Full Text
  136. 136.
    1. Regnard C
    . Use of low-dose thioridazine to control sweating in advanced cancer. Palliat Med 1996;10:78–9.
    OpenUrl
  137. 137.
    1. Al-Adwani A,
    2. Basu N
    . Methadone and excessive sweating. Addiction 2004;99:259.
    OpenUrlPubMed
  138. 138.
    1. Buecking A,
    2. Vandeleur CL,
    3. Khazaal Y,
    4. Zullino DF
    . Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol 2005;61:543–4.
    OpenUrlCrossRefPubMed
  139. 139.
    1. Mago R,
    2. Monti D
    . Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients. J Clin Psychiatry 2007;68:639–40.
    OpenUrlPubMed
  140. 140.
    1. Mago R
    . Antidepressant-induced excessive sweating (ADIES): measurement and treatment. Presented at American Psychiatric Association; 2009; Philadelphia, PA.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords